1. Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma. Issue 2 (February 2015) Authors: Straka, Christian; Salwender, Hans; Schnabel, Brigitte; Sandherr, Michael; Wandt, Hannes; Hübel, Kai; Scheid, Christof; Metzner, Bernd; Hentrich, Marcus; Franke, Daniel; Weidenegger, Gloria; Freund, Mathias; Sezer, Orhan; Einsele, Hermann; Hinke, Axel; Emmerich, Bertold Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗